Christine Jeanne Symula, PHYSICAL THERAPIST | |
10551 Steuben Street, Remsen, NY 13438-0081 | |
(315) 794-4362 | |
Not Available |
Full Name | Christine Jeanne Symula |
---|---|
Gender | Female |
Speciality | Physical Therapist - Pediatrics |
Location | 10551 Steuben Street, Remsen, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669787024 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2251P0200X | Physical Therapist - Pediatrics | 003357-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christine Jeanne Symula, PHYSICAL THERAPIST Po Box 81, Remsen, NY 13438-0081 Ph: (315) 794-4362 | Christine Jeanne Symula, PHYSICAL THERAPIST 10551 Steuben Street, Remsen, NY 13438-0081 Ph: (315) 794-4362 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron-deficiency anemia, announced today the design of its Phase III development program for Soluble Ferric Pyrophosphate (SFP) as a continuous iron replacement therapeutic.
CareFirst BlueCross BlueShield, the largest insurer in the Maryland, Washington and Northern Virginia market, will begin offering financial rewards to physicians who improve quality while cutting costs. Beginning on Jan. 1, the insurer plans to recruit doctors "to participate in its new initiative designed to cut down on the number of unnecessary diagnostic tests, emergency room visits and hospital re-admissions. To do so, CareFirst is putting the onus on the 5,000 doctors already in its network to revamp the care provided to their patients — particularly those with chronic diseases or at risk of contracting them — and more carefully consider where they send patients when they need to see a specialist or go to the hospital."
New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
A survey of yogurt ingredients show that sugar levels have significantly decreased in the last two years, but concerns about overall nutritional content remain.
› Verified 6 days ago